Information For Authors
- Author Benefits Program
- Manuscript Submission Guidelines
- Open Access Policy
- NIH/HHMI Wellcome Trust Policies
- Self-Archiving Policy
Mary Ann Liebert, Inc. Submission Benefits Package
Your submission to Journal of Neurotrauma provides you with robust tools and support to ensure maximum impact and readership for your work. By submitting your manuscript, you’ll receive:
- Rapid, rigorous peer-review and editorial attention
- Immediate deposit to PubMed and other indexing services upon online publication
- Exposure to thousands of thought-leaders in your field, maximizing readers, citations, and downloads
- Fast Track online-ahead-of-print publication
- Global availability in over 170 countries
- Open Access publication options
Submitting Your Manuscript
Submitting your manuscript to Journal of Neurotrauma delivers a comprehensive benefits program that ensures high-quality review of your research and maximum impact for your work. Journal of Neurotrauma carries a manuscript submission fee* of $75.00 USD upon submission of each new manuscript.
Upon payment, you will be provided a Manuscript Submission Code, and will be prompted to enter this information when uploading your files to our peer-review system. Please note: Securing a token does not automatically create an account in our peer-review system. If you do not already have an account, you will be asked to create one before you can begin your submission.
Submissions do not need to be completed at once. Submitting authors/agents may begin the submission process, save their work, and return to the site to complete the upload(s) at a later time. There is no limit on the number of times one can save their work and subsequently resume the submission. Doing so will not incur additional charges.
Click here to submit your paper via our fast and user-friendly electronic submission system.
Processing charges and submission codes are NOT required for revisions to previously submitted papers. To upload a revision of a paper, the submitting author should log in to their Author Center at http://mc.manuscriptcentral.com/neurotrauma and click on “Revised Manuscripts in Draft.” The paper will appear in this area, and the submitting author will be able to upload revised files without paying any charges or entering a submission code.
Please be sure to follow the Instructions for Authors below on Manuscript Preparation. Authors whose submissions do not comply with the Instructions for Authors will have their papers un-submitted so that the file(s) may be adjusted accordingly. Directions regarding the necessary corrective actions will be provided in an email to the corresponding author at the time the paper is un-submitted. The submitting author/agent will then be provided the opportunity to re-upload the corrected file(s). If a paper is un-submitted, the paper will reside in the corresponding author’s “Author Center” as a draft, and the submitting author/agent will be able to make the necessary adjustments and re-upload the paper without incurring another manuscript processing charge.
*The manuscript submission fee is independent of editorial decision and is non-refundable.
Web-Based Electronic Manuscript Submission and Peer Review
All new manuscripts must be submitted online.
Please read the Instructions for Authors before submitting your paper online.
For technical information on using Manuscript Central, contact AuthorServices@liebertpub.com
Instructions for Authors
The Journal of Neurotrauma publishes papers dealing with all aspects of neurotrauma. This includes the anatomy, biochemistry, biophysics, immunology, pathology, pharmacology, and physiology of brain, spinal, and nerve injury. Papers published in this journal emphasize morphological, physiological, and biochemical studies of injured neurons and glial cells, mechanisms and treatments of acute and chronic injury of the nervous system, neural and glial regeneration, transplantation, in vivo and in vitro injury models, cellular growth factors, blood flow, and metabolism of injured nervous tissues, and recovery of function. Both laboratory and clinical studies are encouraged.
The journal will consider original research papers, short communications, reviews, and letters to the editor. Case reports are not accepted by the Journal. All submissions, except letters, must be accompanied by an abstract of about 250 words and keywords (<5). Original research papers should have an Introduction, Materials and Methods, Results, and Discussion sections. Short communications should have no sections and 6 manuscript pages or less, two tables or two figures or one of each. Reviews are invited and will be considered.
Page charges for this journal are set at $55.00 USD per typeset page. Nonpayment of page charges may result in a delay in publication. Costs for printing images in color are a separate fee and are not included in the page charge total.
SUBMISSION OF MANUSCRIPTS
Submissions to the journal will be reviewed by the editorial board. Every effort will be made to ensure a speedy review and a publication time of less than 6 months. Members of the editorial board will formulate a critique of the submitted manuscript. This critique will be sent to the author and, under special circumstances, may be published at the conclusion of the paper if the manuscript is accepted. A submitted manuscript (or any part of its essential substance) must not have been published or submitted for publication elsewhere before appearance in this journal (except abstracts in connection with scientific meetings). The journal is not responsible for lost manuscripts.
Please read all the instructions to authors before submitting.
Full mailing information should be included if not on title page, then the following page. Corresponding author should be identified on title page. Prepare text double-spaced throughout. Leave ample margins on sides, top and bottom of the page. Please submit text in Microsoft Word. On the first page, give the full title of the paper, full name(s) and institutional affiliation(s) of author(s) with the highest academic degrees and institutional titles. Provide a running title (<45 characters) and a Table of Contents title (<75 characters), if the full title is longer than these limits. We require the full mailing address and contact information (telephone, fax, and e-mail address) for EACH author listed on your article. Please include the address (es). Please also indicate the corresponding author. Supply an abstract (<250 words) which presents the reasons for the study, the main findings (with specific data), the principal conclusions, and a list of key words (maximum of 5). Original research papers should contain the following sections: introduction, materials and methods, results, discussion, acknowledgments, references, tables, and figure legends. One subsection level is allowed. Short communications should be prepared similarly to original papers. Begin each section on a separate page.
INSTANT ONLINE PUBLICATION
The Journal publishes all accepted papers within 72 hours of acceptance in their unedited, uncorrected format. It is important to note that the information that is published online, and in all indexing services, is pulled directly from the data that is populated into the fields in Manuscript Central – NOT from the manuscript file – when the paper is originally uploaded to the system for peer review. Consequently, any errors contained in the system will remain on our website and all indexing services, including Medline, until the next revision of the article is published. As such, it is critical that authors enter all authors’ names correctly into the system at the time of submission.
The next revision will take place after the corresponding author sees page proofs, makes any necessary corrections, and returns the changes to the Publisher. Once the alterations are completed, the revised version will be published on our website, and the newly corrected information will then be released to Medline/PubMed, in addition to any other indexing services in which the Journal is included.
Please note that the typical time between acceptance of a paper and page proof distribution is approximately 4-8 weeks depending on the length and complexity of the paper.
Journal of Neurotrauma is updating its referencing style to the numbered reference system. All submitted manuscripts should be prepared according to this new style. Please see below for the revised instructions.
New Reference Style
Authors are responsible for the accuracy and completeness of their references. Number all references in the order they are cited in the text; do not alphabetize. In-text citations should be in numerical order, superscripted, not contained within parentheses or brackets, and placed after punctuation. All references in text should be included in the reference list, and all references in the reference list should have a corresponding citation in the main text of the manuscript.
Preparation of Reference Section:
- Begin the Reference section on a separate page after the Author Disclosure Statement section
- Double-space entire section
- Personal communications, unpublished data, or manuscripts “in preparation” or “submitted for publication” should not be included in the Reference section. If necessary, these should be included at the appropriate place in the body of the text. Personal communications should include the contact’s first initial and last name, and the month and year of the communication.
- List all authors and/or editors for each listed article.
- Abbreviate journal titles in accordance with PubMed/Medline (www.ncbi.nlm.nih.gov/pubmed/)
- For journal article titles, capitalize only the first letter of the title.
- References to abstracts should be indicated as such, with the abstract number included, if applicable
- For book citations, volume and edition numbers should be included when appropriate.
Lieutaud, T., Ndiaye, A., Laumon, B., and Chiron, M. (2012). Spinal cord injuries sustained in road crashes are not on the decrease in France: a study based on epidemiological trends. J. Neurotrauma 29, 479-487.
Bele, S., and Brawanski, A. (2009). Biomarkers and surrogate markers, in: Neurotrauma and Critical Care of the Brain. J. Jallo, and C.M. Loftus (eds). Theime Publishing: New York, pps. 42-52.
TABLE AND ILLUSTRATIONS
Type tables double-spaced in a separate file, number tables with Arabic numerals, and provide a legend for each table. Tabular data should not be duplicated in figures.
The top of the illustration should be indicated. A legend should be supplied for each illustration, and all legends numbered consecutively and provided (double-spaced) in a separate file. Figures should be numbered in the order cited in the text. A complete set should be submitted the manuscript. Images should not show the name of the manufacturer. Please keep in mind that the figures will be reduced, so please do not submit large figures/graphs that contain small type, as the text within the figure will not be readable after reduction. Photomicrographs should be cropped to 8cm width. Electron photomicrographs should have internal scale markers. If a figure consists of two or more parts, individual parts should have similar dimensions.
Please follow these instructions carefully when preparing figure files for uploading:
- Do not include any illustrations as part of your text file.
- Do not prepare any figures in Word as they are not workable and will be rejected for production.
- Line illustrations must be submitted at 900 DPI.
- Halftones and color photos should be submitted at a minimum of 300 DPI. (NB: 600 DPI images are more desirable for production).
- PowerPoint files cannot be uploaded to Manuscript Central.
- Save art as either TIFF or EPS files. Do not submit JPEG files. (JPEG files are for screen representation-quality only and will print very poorly during the printing process.) To ensure proper print quality, please submit only TIFF or EPS files.
- Color art must be saved as CYMK not RGB. (NB: If RGB files are submitted, the files will be converted to CYMK and some color variation will occur).
- Label figures and tables inside the files in addition to naming the file with the figure or table number. (I.e., When figures or table files are opened, the figure or table number should appear inside the file.)
- When naming your figure files, please label them with your last name, followed by a period (.), and then list the figure number. Ex: Smith.Fig 1. Label figures and tables inside the files in addition to naming the file with the figure or table number. (I.e., when figure or table files are opened, the figure or table number should appear inside the file.)
Color illustrations can be printed in the journal with a subsidy from the author(s). Please contact the Publisher for further details.
Please upload individual files of all manuscript material—do NOT upload a single PDF file containing all text, figure, and table files of your paper. Once all individual files are uploaded on to Manuscript Central, the system will automatically create a single PDF proof for you and the peer-review process.
Immediately following the Acknowledgments section, include a section entitled “Author Disclosure Statement.” In this portion of the paper, authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the Journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. This information will remain confidential while the paper is being reviewed and will not influence the editorial decision. Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals at http://www.icmje.org/index.htlm#conflicts for further guidance. If no conflicts exist, the authors must state “No competing financial interests exist."
If no conflicts exist, the authors must state “No competing financial interests exist."
ABBREVIATIONS, NOMENCLATURE, AND SYMBOLS
Consult the “Style Manual for Biologic Journals,” 4th Edition, 1978 (American Institute of Biological Sciences, 1401 Wilson Blvd, Arlington, VA 22209.) Identify medications, materials, and devices by full nonproprietary name, brand name, and the manufacturer’s name, city, state, and country. Place this information in parentheses in the text.
Materials taken from other sources must be accompanied by a written statement from both author and publisher giving permission to the journal for reproduction. If clearances are required by the author’s institution, statements concerning such clearance should be provided in the manuscript.
ANIMAL OR HUMAN EXPERIMENTATION
Reports of research involving human and/or animal experimental subjects should be accompanied by a statement to the Editor, indicating approval by an Institutional Animal Care and Use Committee, Institutional Review Board or equivalent.
Page proofs are sent to the corresponding author via e-mail, so please be sure to have any e-mail filters accept e-mail from the liebertpub.com domain. Please ensure that proper e-mail addresses are given.
Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.
The statements and opinions expressed in JOURNAL OF NEUROTRAUMA are those of the individual contributors, editors, or advertisers; they do not necessarily represent the views of the other editors or the publisher. Unless specified otherwise, the authors and publisher disclaim any responsibility or liability for such material.
The Journal is published by Mary Ann Liebert, Inc., publishers, 140 Huguenot Street, Floor, New Rochelle, NY 10801-5215. Telephone (914) 740-2100, Fax (914) 740-2101, e-mail: firstname.lastname@example.org, home.liebertpub.com
Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) option
Does your research funder have an open access mandate or would you like to expand the dissemination of your research?
The Liebert Open Access option enables authors to publish open access in our esteemed subscription-based journals.
The benefits of Liebert Open Access include:
- High visibility; open access articles are freely available online upon publication
- You retain copyright with the open access license allowing broad dissemination of your research
- You can freely share your article in repositories and research networks without restrictions
- Easy compliance with open access mandates
- Rigorous editorial and peer-review
- Targeted email announcement featuring a direct link to article
Identification and Marketing
Open access articles are listed with an OA icon in journal tables of content (TOC), TOC alerts, and in marketing announcements. Open access articles are highlighted and promoted in targeted email announcements to thousands of research leaders in your field.
Copyright and Licensing
If you choose to publish with open access, you will retain copyright of your article and a Creative Commons license will be applied. The liberal Creative Commons Attribution 4.0 (CC-BY) license is the default open access license used at Mary Ann Liebert, Inc., publishers. The CC-BY license permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
At this time we allow authors to choose between the CC-BY or CC-BY-NonCommercial license. A limited number of journals offer NonCommercial licenses exclusively.
Ordering Open Access
Once your article has been accepted for publication in a journal, you will receive an email with information on ordering Liebert Open Access. If you would like more information about Liebert Open Access or would like to order open access, please email email@example.com.
Publishing open access includes an article publication charge (APC) and authors are asked to fill out a short open access order form. You can pay by credit card or receive an invoice to be returned with payment or via bank transfer. Please remember that traditional subscription journals can carry mandatory or optional author fees. The Liebert Open Access APC does not cover or replace existing publication or author fees.
Publishing biomedical or biotechnology research?
Biomedical researchers should consider publishing in BioResearch Open Access, a fully open access peer-reviewed journal dedicated to publishing top research in the biomedical and biotechnology fields. For details, please visit the information for authors on the journal website.
*Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.
Browse journals in the Liebert Open Access portfolio:
NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.
Publishing in Subscription Journals
By signing the copyright transfer statement, authors still retain a set of rights that allow for self-archiving.
Authors may archive their preprint manuscripts (version prior to peer review) at any time without restrictions. Authors may archive their postprint manuscripts (accepted version after peer review) in institutional repositories, preprint servers, and research networks after a 12 month embargo. The 12 month embargo period begins when the article is published online. Postprints must not be used for commercial purposes and acknowledgement must be given to the final publication, and publisher, by inserting the DOI number of the article in the following sentence: “Final publication is available from Mary Ann Liebert, Inc., publishers http://dx.doi.org/[insert DOI]”. Authors may archive on their personal website without an embargo provided their manuscript is updated with an acknowledgement to the publisher copyright and final published version.
The final published article (version of record) can never be archived in a repository, preprint server, or research network.
Publishing Open Access
Authors that wish to easily comply with funder or institutional open access mandates should consider publishing open access. Liebert Open Access option allows authors to make their research freely available online without restrictions. Additionally, Liebert Open Access option allows authors to retain copyright, archive and share the final published version of their article without restrictions. To publish open access please email firstname.lastname@example.org or visit Liebert Open Access for more information.